SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-002583
Filing Date
2020-04-27
Accepted
2020-04-27 06:02:10
Documents
10
Period of Report
2020-06-11
Effectiveness Date
2020-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241370zdef14a.htm DEF 14A 803246
2 G774066.JPG g774066.jpg GRAPHIC 15934
3 G714606.JPG g714606.jpg GRAPHIC 9810
4 G980415.JPG g980415.jpg GRAPHIC 5045
5 G152214.JPG g152214.jpg GRAPHIC 12444
6 G824021.JPG g824021.jpg GRAPHIC 7987
7 G914459.JPG g914459.jpg GRAPHIC 155742
8 G574074.JPG g574074.jpg GRAPHIC 43103
9 G158272BCI001.GIF g158272bci001.gif GRAPHIC 82572
10 G158272BCI002.GIF g158272bci002.gif GRAPHIC 59454
  Complete submission text file 0001047469-20-002583.txt   1345523
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38905 | Film No.: 20817063
SIC: 2834 Pharmaceutical Preparations